CSIMarket Company Name, Ticker, Suppliers, else..
 
Vistagen Therapeutics Inc   (NASDAQ: VTGN)
 

Vistagen Therapeutics Inc's Suppliers Performance

VTGN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
VTGN Costs vs Sales of Suppliers Growth

• More on VTGN Suppliers






Vistagen Therapeutics Inc's Comment on Supply Chain


The company does not own or operate manufacturing facilities for drug substances or products and relies on various Contract Development and Manufacturing Organizations (CDMOs) for nonclinical and clinical trial requirements. It conducts quality audits to ensure CDMOs comply with current Good Manufacturing Practices (cGMPs) and assesses that existing CDMOs can meet projected needs. The company currently has no long-term supply agreements with CDMOs but intends to establish such agreements if its products receive approval for commercial distribution. Additionally, the company plans to mitigate supply risks by managing inventory levels and exploring backup manufacturers both in the United States and internationally to diversify its supply chain.

Vistagen Therapeutics Inc's Comment on Supply Chain


The company does not own or operate manufacturing facilities for drug substances or products and relies on various Contract Development and Manufacturing Organizations (CDMOs) for nonclinical and clinical trial requirements. It conducts quality audits to ensure CDMOs comply with current Good Manufacturing Practices (cGMPs) and assesses that existing CDMOs can meet projected needs. The company currently has no long-term supply agreements with CDMOs but intends to establish such agreements if its products receive approval for commercial distribution. Additionally, the company plans to mitigate supply risks by managing inventory levels and exploring backup manufacturers both in the United States and internationally to diversify its supply chain.







VTGN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Vistagen Therapeutics Inc 18.88 2.50 -67.62 41
SUBTOTAL 0.00 0.00 0.00 -


Sources: Vistagen Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Vistagen Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.